157 — Natural Beauty Bio-Technology Balance Sheet
0.000.00%
- HK$961.01m
- HK$1.06bn
- HK$353.65m
Annual balance sheet for Natural Beauty Bio-Technology, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 162 | 193 | 169 | 167 | 117 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 116 | 116 | 79.2 | 83.2 | 72.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 400 | 450 | 365 | 343 | 289 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 370 | 417 | 238 | 271 | 274 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 832 | 930 | 872 | 872 | 773 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 205 | 238 | 251 | 283 | 188 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 221 | 273 | 275 | 298 | 325 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 611 | 658 | 597 | 575 | 448 |
Total Liabilities & Shareholders' Equity | 832 | 930 | 872 | 872 | 773 |
Total Common Shares Outstanding |